메뉴 건너뛰기




Volumn 12, Issue SUPPL. 1, 2005, Pages 22-30

Low-molecular-weight heparin and survival in patients with malignant disease

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXAN; DALTEPARIN; EPIRUBICIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; VINCRISTINE; WARFARIN;

EID: 25144496456     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073274805012003s05     Document Type: Review
Times cited : (31)

References (24)
  • 1
    • 0034700438 scopus 로고    scopus 로고
    • Prognosis of cancers associated with venous thromboembolism
    • Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846-1850.
    • (2000) N Engl J Med , vol.343 , pp. 1846-1850
    • Sorensen, H.T.1    Mellemkjaer, L.2    Olsen, J.H.3
  • 2
    • 13244251018 scopus 로고    scopus 로고
    • Thrombosis and cancer: Implications beyond Trousseau
    • Kakkar AK, Levine MN. Thrombosis and cancer: implications beyond Trousseau. J Thromb Haemost. 2004;2:1-2.
    • (2004) J Thromb Haemost , vol.2 , pp. 1-2
    • Kakkar, A.K.1    Levine, M.N.2
  • 3
    • 0026762705 scopus 로고
    • Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin
    • Green D, Hull RD, Brant R, et al. Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet. 1992; 339:1476.
    • (1992) Lancet , vol.339 , pp. 1476
    • Green, D.1    Hull, R.D.2    Brant, R.3
  • 4
    • 0029925784 scopus 로고    scopus 로고
    • Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
    • Siragusa S, Cosmi B, Piovella F, et al. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med. 1996;100:269-277.
    • (1996) Am J Med , vol.100 , pp. 269-277
    • Siragusa, S.1    Cosmi, B.2    Piovella, F.3
  • 5
    • 0032699382 scopus 로고    scopus 로고
    • Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread
    • Hettiarachchi R, Smorenburg S, Ginsberg J, et al. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread. Thromb Haemost. 1999;82:947-952.
    • (1999) Thromb Haemost , vol.82 , pp. 947-952
    • Hettiarachchi, R.1    Smorenburg, S.2    Ginsberg, J.3
  • 6
    • 0032955744 scopus 로고    scopus 로고
    • Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep vein thrombosis: A meta-analysis of randomized, controlled trials
    • Gould MK, Dembitzer AD, Doyle RL, et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep vein thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med. 1999;130:800-809.
    • (1999) Ann Intern Med , vol.130 , pp. 800-809
    • Gould, M.K.1    Dembitzer, A.D.2    Doyle, R.L.3
  • 7
    • 3042704507 scopus 로고    scopus 로고
    • Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
    • Kakkar AK, Levine MN, Kadziola Z, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS). J Clin Oncol. 2004;22:1944-1948.
    • (2004) J Clin Oncol , vol.22 , pp. 1944-1948
    • Kakkar, A.K.1    Levine, M.N.2    Kadziola, Z.3
  • 8
    • 0037775584 scopus 로고    scopus 로고
    • Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
    • Lee AYY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
    • (2003) N Engl J Med , vol.349 , pp. 146-153
    • Lee, A.Y.Y.1    Levine, M.N.2    Baker, R.I.3
  • 9
    • 17144385138 scopus 로고    scopus 로고
    • Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism
    • Lee AYY, Rickles FR, Julian JA, et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol. 2005;23:2123-2129.
    • (2005) J Clin Oncol , vol.23 , pp. 2123-2129
    • Lee, A.Y.Y.1    Rickles, F.R.2    Julian, J.A.3
  • 10
    • 12844289104 scopus 로고    scopus 로고
    • A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
    • Altinbas M, Coskun HS, Er O, et al. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost. 2004;2:1-6.
    • (2004) J Thromb Haemost , vol.2 , pp. 1-6
    • Altinbas, M.1    Coskun, H.S.2    Er, O.3
  • 11
    • 20244376337 scopus 로고    scopus 로고
    • The effect of low molecular weight heparin on survival in patients with advanced malignancy
    • Klerk CPW, Smorenburg SM, Otten HM, et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol. 2005;23:2130-2135.
    • (2005) J Clin Oncol , vol.23 , pp. 2130-2135
    • Klerk, C.P.W.1    Smorenburg, S.M.2    Otten, H.M.3
  • 12
    • 0037775639 scopus 로고    scopus 로고
    • Cancer-associated thrombosis
    • Bick RL. Cancer-associated thrombosis. N Engl J Med. 2003;349:109-111.
    • (2003) N Engl J Med , vol.349 , pp. 109-111
    • Bick, R.L.1
  • 14
    • 0031927754 scopus 로고    scopus 로고
    • Thrombin receptor overexpression in malignant and physiological invasion processes
    • Even-Ram S, Uziely B, Cohen P, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998;4:909-914.
    • (1998) Nat Med , vol.4 , pp. 909-914
    • Even-Ram, S.1    Uziely, B.2    Cohen, P.3
  • 15
    • 0029097464 scopus 로고
    • Tissue factor expression correlates with histological grade in human pancreatic carcinoma
    • Kakkar AK, Lemoine NR, Scully MF, et al. Tissue factor expression correlates with histological grade in human pancreatic carcinoma. Br J Surg. 1995;82:1101-1104.
    • (1995) Br J Surg , vol.82 , pp. 1101-1104
    • Kakkar, A.K.1    Lemoine, N.R.2    Scully, M.F.3
  • 16
    • 0032498848 scopus 로고    scopus 로고
    • A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280
    • Ott I, Fischer EG, Miyagi Y, et al. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol. 1998;140:1241-1253.
    • (1998) J Cell Biol , vol.140 , pp. 1241-1253
    • Ott, I.1    Fischer, E.G.2    Miyagi, Y.3
  • 17
    • 0024593040 scopus 로고
    • Control of angiogenesis with synthetic heparin substitutes
    • Folkman J, Weisz PB, Joullie MM, et al. Control of angiogenesis with synthetic heparin substitutes. Science. 1989;243:1490-1493.
    • (1989) Science , vol.243 , pp. 1490-1493
    • Folkman, J.1    Weisz, P.B.2    Joullie, M.M.3
  • 18
    • 0033057962 scopus 로고    scopus 로고
    • Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
    • Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med. 1999;5:793-802.
    • (1999) Nat Med , vol.5 , pp. 793-802
    • Vlodavsky, I.1    Friedmann, Y.2    Elkin, M.3
  • 19
    • 25144517952 scopus 로고    scopus 로고
    • The low molecular weight heparin dalteparin sodium inhibits angiogenesis and induces apoptosis in an experimental tumour model
    • Abstract
    • Nasir FA, Patel HK, Scully MF, et al. The low molecular weight heparin dalteparin sodium inhibits angiogenesis and induces apoptosis in an experimental tumour model. Blood. 2003;102(11). Abstract.
    • (2003) Blood , vol.102 , Issue.11
    • Nasir, F.A.1    Patel, H.K.2    Scully, M.F.3
  • 20
    • 0035853111 scopus 로고    scopus 로고
    • Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
    • Borsig L, Wong R, Feramisco J, et al. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A. 2001;98:3352-3357.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 3352-3357
    • Borsig, L.1    Wong, R.2    Feramisco, J.3
  • 21
    • 13244275111 scopus 로고    scopus 로고
    • Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway
    • Miller GJ, Bauer KA, Howarth DJ, et al. Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J Thromb Haemost. 2004;2:2107-2114.
    • (2004) J Thromb Haemost , vol.2 , pp. 2107-2114
    • Miller, G.J.1    Bauer, K.A.2    Howarth, D.J.3
  • 22
    • 0034729786 scopus 로고    scopus 로고
    • Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism: Duration of Anticoagulation Trial
    • Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism: Duration of Anticoagulation Trial. N Engl J Med. 2000;342:1953-1958.
    • (2000) N Engl J Med , vol.342 , pp. 1953-1958
    • Schulman, S.1    Lindmarker, P.2
  • 23
    • 4644288189 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism
    • The Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy
    • Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. The Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):338S-400S.
    • (2004) Chest , vol.126 , Issue.3 SUPPL.
    • Geerts, W.H.1    Pineo, G.F.2    Heit, J.A.3
  • 24
    • 4644221063 scopus 로고    scopus 로고
    • Antithrombotic therapy for venous thromboembolic disease
    • The Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy
    • Büller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):401S-428S.
    • (2004) Chest , vol.126 , Issue.3 SUPPL.
    • Büller, H.R.1    Agnelli, G.2    Hull, R.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.